On November 21, 2024, Scinai Immunotherapeutics Ltd. held its Annual Meeting, where shareholders approved the re-elections of several board members and an increase in authorized shares. A total of 3,411,774,240 shares were represented, ensuring a quorum for the decisions made during the meeting.